STI Expert Hour Webinar – DoxyPEP 2.0: People Assigned Female Sex at Birth

November 12, 2024
12:30PM-2:00PM (PST)

Presenter:
Jenell Stewart, DO, MPH

CME not available for viewing the webinar recording.

Learning Objectives

Guide evidence-based shared decision-making conversations with individual patients who were assigned female sex at birth.
Assess potential benefits and risks at a population and individual level of DoxyPEP use among people who were assigned female sex at birth.

September 2023 Focus on youth: Improving HIV Prevention and Sexual Health Services for Adolescents and Youth Adults

September 28, 2023

September 2024Injectable PrEP Update: Whitman-Walker Community Health Worker PrEP Program

September 19, 2024

Slide Deck 1

Slide Deck 2

September 2024 Injectable PrEP Update

Special guest: Juan Carlos Loubriel, Senior Director of Community Health and Wellness at Whitman-Walker Health (Washington, DC). Juan Carlos will talk about Whitman-Walker’s innovative program for injectable PrEP initiation and administration by community health workers.

Thursday, September 19, 12-1pm PT

Slides 1, Slides 2

July 2024 PrEP Learning Collaborative Injectable PrEP Update

Thursday, July 18, 12-1pm PDT

Slides

Special Guest: Stefan Madzar, PrEP & HIV Benefits Coordinator & Linkage Navigator at Magnet (San Francisco AIDS Foundation).

Stefan will present an update on Magnet’s injectable PrEP program, including challenges, successes, and lessons learned, and featuring clients who will discuss their experiences taking injectable PrEP.

STI Clinical Update Webinar– Summer 2024 Update and Review: Syphilis, Chlamydia, and Gonorrhea, County of Lake

Presented by Drs. Kelly Johnson and Kurtis Mohr
Wednesday, July 24, 2024
11:00AM – 1:00PM (PDT)

CME not available for viewing the webinar recording.

Learning Objectives

Describe the varied clinical manifestations of primary and secondary syphilis in adults and adolescents
Appropriately stage and treat syphilis in both pregnant and non-pregnant people
Recognize the different sequelae of sexually transmitted C. trachomatis and N. Gonorrhoeae infections & their recommended treatments

May 2024 HIV PEP Update

May 2, 2024

CAPTC HIV PEP Overview (Slides)

PEP at San Francisco City Clinic (Slides)

PEP in Sexual Assault: St. Louis, MO (Slides)

TelePEP in California (Slides)

Public Policy and PEP: Oregon and Washington (Slides)

STI Clinical Update Webinar – Syphilis: A Case-Based Review and Update

March 28, 2024

9:30AM-11:00AM (MT)

Presented by Dr. Kelly Johnson

Please note: CME not available for viewing the webinar recording.

Learning Objectives:

List common causes for genital ulcerative disease
Interpret results of traditional & reverse syphilis screening algorithms
Explain the clinical significance of changes in non-treponemal titers
Name a resource for help interpreting different combinations of serologic results

2024 STI Clinical Update: San Francisco Department of Public Health (SFDPH)

Thursday, March 14, 2024

Hybrid event. Please note: CME not available for viewing the recording.

Presented by:

Dr. Oliver Bacon
Medical Director, San Francisco City Clinic
San Francisco Department of Public Health

Dr. Franco Chevalier
Deputy Medical Director, San Francisco City Clinic
San Francisco Department of Public Health

Dr. Stephanie Cohen
Director, HIV/STI Prevention, Disease Control Branch,
San Francisco Department of Public Health

Dr. Kelly Johnson
Medical Director, California Prevention Training Center
Public Health Medical Officer, STD Control Branch, California Department of Public Health

Emcee: Dr. Ina Park
Principal Investigator, California Prevention Training Center

Description

More than 2.5 million cases of chlamydia, gonorrhea, and syphilis were reported in the U.S. in 2022, and San Francisco has higher chlamydia, gonorrhea, syphilis, and HIV rates compared to the rest of the state and nation. This half-day, hybrid event will provide important updates in the field of sexual health to help providers strengthen the delivery of STI prevention and care. Hear from local experts on STI epidemiology in San Francisco, updates on Doxy-PEP implementation, recognizing dermatologic manifestations of STIs, and a lively case panel.

Learning Objectives

Summarize current STI trends in San Francisco
Be familiar with updates to STI treatment guidelines and innovations in STI prevention and diagnostics
Understand how to implement Doxy-PEP for STI prevention
Recognize common dermatologic manifestations of STIs

February 2024 Injectable PrEP Update